The inducible heat shock protein 70 (Hsp70) is both cytoprotective and immunomodulatory, 25 potentially accounting for its critical role in maintaining gastrointestinal homeostasis. When 26 levels are reduced in conditions like inflammatory bowel diseases (IBD), loss of function 27 contributes to the severity and chronicity of these diseases, although through which cell types 28 and mechanisms remains unclear. Here, the role of Hsp70-mediated intestinal epithelial 29 protection and immune regulation in experimental colitis was examined by using a villin-30 promoter driven Hsp70 transgene in the TNBS and DSS models and in IL10/Hsp70 double 31
INTRODUCTION 47
Inducible intestinal heat shock proteins (Hsps) such as Hsp70 play essential roles in maintaining 48 mucosal homeostasis, although it is still unclear what processes and cell types mediate these 49 actions. While most of these proteins are only expressed under conditions of stress, the 50 constitutive expression of Hsp70 in the colonic epithelium appears to be largely maintained by 51 microbial stimuli, including toll like receptor (TLR) ligands, short chain fatty acids, and small 52 bioactive microbial peptides (1, 14, 16, 18, 40) . Hsp70 knock out mice (where Hsp70.1 and 53
Hsp70.3 are specifically targeted), for example, are highly susceptible to chemically and 54 genetically induced experimental colitis (17). In Hsp70 -/-mice, dextran sodium sulfate (DSS) 55 causes a chronic and severe colitis, whereas most wild type mice will spontaneously recover. 56
Ironically, colonic mucosal expression of Hsp70 is significantly decreased in both human and 57 experimental colitis, which in the latter appears to be mediated through translational down-58 regulation involving the 3'untranslated region of the Hsp70 transcript (15). Forced expression of 59
Hsp70 in intestinal epithelial cell through a villin promoter-driven UTR-less Hsp70 transgene 60 partially mitigates the mucosal injury induced by DSS, suggesting that Hsp70 in this cell type 61 can have therapeutic benefit (17). Finally, another illustration of the importance of Hsp70 in the 62 gut is the accelerated development of colon cancer in Hsp70 -/-/IL-10 -/-double KO mice (38) . 63 64 Collectively, these findings implicate essential roles of Hsp70 function in the intestinal mucosa 65 relevant to states of health, but also to the development of inflammatory diseases of the bowel. 66
In the present study, we examined the possibility that Hsp70 in different gut mucosal cell types 67 has distinct roles and mechanisms of action that are important for mucosal cytoprotection and 68 immune regulation, when compromised in conditions of immune and inflammatory stress, 69 contribute to the severity and duration of disease. We utilized four different experimental colitis 70 models in this study. Two important protective functions of Hsp70 were elucidated in promoting 71 intestinal homeostasis and limiting inflammation-associated mucosal injury. Epithelial specific 72 expression of Hsp70 protected Hsp70 -/-mice from DSS-induced colitis and decreased the 73 penetrance of colitis in IL10 -/-/Hsp70 -/-mice. Diminished production of IL-10 in Hsp70 -/-mice 74 was associated with impaired ERK phosphorylation in immunocytes and rendered mice sensitive 75 to 2,4,6-trinitrobenzene sulfonic acid (TNBS) induced colitis. The finding that Treg cells from 76
Hsp70
-/-mice were not able to rescue CD45RB high induced colitis in Rag -/-mice further 77
demonstrates that the intracellular anti-inflammatory function of Hsp70 requires IL-10 78 production. 79
80

MATERIALS AND METHODS 81
Animals 82
Conventionalized wild type (WT) C57BL/6J, Hsp 70.1 and 70.3 deficient (Hsp70 
2,4,6-trinitrobenzene sulfonic acid (TNBS) induced colitis 90
Mice were pre-sensitized by back injection of mixture of acetone/olive oil/TNBS 7 days before 91 the administration of TNBS (Sigma Chemical Co, St Louis, MO, USA). On the day of 92 experiment, mice were anesthetized, 2 mg TNBS was rectally introduced by using a 3.5F 93 catheter. Weight was measured on the following day and daily, tissue collection was performed 94 on day 7. Histological grading of intestinal inflammation was performed as described previously 95 (4). 96
97
DSS-induced colitis 98
Mice were given 2% DSS (ICN Chemicals, Costa Mesa, CA) in drinking water for 7 days. 99
Weight changes, diarrhea, bloody stool, and overall health were monitored over time. Mice were 100 euthanized with sevoflurane and tissues were collected at day 10. Histological grading of 101 intestinal inflammation was performed as previously described (17). 102
103
FITC-Dextran Permeability Assay 104
Intestinal permeability was assessed by luminal enteral administration of FITC-dextran 10,000 105 (Sigma) (9). All mice were gavaged with FITC-dextran (40 mg/100 g body weight) 4 h before 106 blood collection. Whole blood was obtained by retro-orbital puncture, and FITC-dextran 107 measurements were performed in duplicate by fluorometry. Dilutions of FITC-dextran in PBS 108 were used as a standard curve, and absorption of 100 μL of serum or standard was measured in a 109 fluorometer at 488 nm. 110
111
Immunofluorescence staining 112
Sections were prepared as described for immunohistochemistry staining (17, 23). The specimens 113 were blocked and then followed by overnight incubation with rabbit anti-ZO-1 (Invitrogen). 114
Sections were washed and then incubated with Cy2-anti-mouse and Cy5 anti-rabbit (Jackson 115
ImmunoResearch, West Grove, PA). Nuclear stating was performed using 4′,6-diamidino-2-116 phenylindole (DAPI; Molecular Probes, Eugene, OR). Confocal microscopy was performed 117 using a Leica SP2AOBS system (Leica, Wetzlar, Germany) intraperitoneally injected into Rag -/-mice respectively. The mice were followed for another 10 129 weeks before the tissue collection. Histological grading of intestinal inflammation for adoptive 130 transfer colitis and IL-10 deficient spontaneous colitis was performed as described previously 131 (12). 132
133
Cell isolation and in vitro stimulation 134
Spleens and mesenteric lymph nodes were collected from 8 weeks old WT and Hsp70 -/-mice, 135
and then splenocytes and lymphocytes were isolated by sifting through 70 um cell strainers. B 136 and T cells were purified by using EasySep T cell negative selection kits according to the 137 manufacturer's instructions. Macrophages as well as dendritic cells were purified by using 138 IL-10 were Forward 5'-160 GCTCTTACTGACTGGCATGAG-3'; Reverse 5'-CGCAGCTCTAGGAGCATGTG-3' and 161 GAPDH were 5′-GGCAAATTCAACGGCACAGT-3′ and 5′-AGATGGTGATGGGCTTCCC-162 3′. Real-time PCR was performed in an iCycler (Bio-Rad, Hercules, CA) using iQSYBR Green 163 PCR Supermix (Bio-Rad). A two-step quantification cycling protocol was used. The Ct value is 164 defined as the cycle number at which the fluorescence crosses a fixed threshold above the 165 baseline. As a relative quantification, the relative gene expression ratio changes were measured 166 using ΔCt method as described previously (16). 167
168
Mononuclear cells preparation and flow cytometry 169
Lymphocytes were isolated from mesentery lymph node and spleen as described previously. 170
Cells were assessed by surface marker staining using specific antibodies to CD4 and CD45RB 171 (BD Biosciences). Cells were permeabilized with the CytoFix/CytoPerm kit (BD Biosciences) 172 for intra-cytoplasmic detection of IL-10 and IFN-γ cytokines (eBioscience). Flow cytometry 173 analysis was performed with a FACsCanto (BD Biosciences) 174
175
ELISA 176
Cytokines in colonic tissue, mesenteric lymph node and cell culture supernatant (as listed in 177 experimental method), were analyzed at different conditions by using mouse ELISA kits from 178 eBioscience. 179
180
Statistical analyses 181
Results are reported as the mean ± SD. Pairwise comparisons were made using the one-or two-182 tailed unpaired Student's t test, while one-way ANOVA with Bonferroni's post-hoc testing was 183 used for multiple comparisons. Calculations were performed using Graphpad Prism software. A 184 P value of less than 0.05 was considered as statistical significant. 185
186
RESULTS
187
DSS-and TNBS-induced colitis models 188
We crossed Hsp70 -/-mice with villin promoter-driven Hsp70 transgenic mice (Hsp70 To test the protective role of Hsp70 in experimental colitis, these mice were challenged with 196 TNBS and DSS separately. The TNBS-induced colitis model exemplifies a Th1-mediated 197 mucosal inflammation which previous studies have shown can be mitigated by 24) . 198
We hypothesized that if intracellular Hsp70 affects host immune function, the gene-targeted 199 deletion of Hsp70 would render mice more susceptible to TNBS-induced colitis and that 200 epithelial specific expression of Hsp70 will be ineffective in preventing this outcome. Three 201 groups of mice were first treated with TNBS rectally and followed overtime. As shown in Fig. 1,  202 
B-D, TNBS treatment resulted in severe colitis in both Hsp70
-/-and Hsp70 -/-/V-TG mice, 203 characterized by extensive leukocytic infiltration, marked colonic mucosal destruction, and 204 mucosal edema (Fig. 1B) . These mice experienced significant weight loss and had high 205 histological colitis scores during the acute phase of TNBS-induced colitis compared to WT mice. 206
Moreover, compared with Hsp70 -/-mice, no significant differences of weight loss and tissue 207 damage were found in Hsp70 -/-/V-TG mice (Fig. 1, C and D) . These data support the notion that 208 systemic expression instead of epithelial expression of Hsp70 is necessary to protect against 209 Th1-mediated colitis. Consistent with histological observations, the highest levels of pro-210 inflammatory cytokines (IFN-γ, IL-12p40 and IL-6) were observed in the colon of Hsp70 -/-and 211
Hsp70
-/-/V-TG mice. Interestingly, mucosal IL-10 expression appeared to be inversely correlated 212 with the presence of intracellular Hsp70 in these mice. In addition, no significant differences of 213 IL-10 production in colonic tissue homogenates were found between Hsp70
-/-and Hsp70
Using the flow cytometry, we also found that there were increased IFN-γ and 215 decreased IL-10 expressions in CD4 + T cells from mesenteric lymph nodes that lacked Hsp70 216 expression, i.e. collected from Hsp70
-/-and Hsp70 -/-/V-TG mice compared to those from WT mice 217
(data not shown). 218 219
However, epithelial-specific expression of Hsp70 revealed significant protection from DSS-220 induced colitis, which is believed to initially arise from stress and injury of gut epithelial cells 221 with associated loss of barrier function (21, 33). These findings were consistent with what we 222 reported previously, i.e. Hsp70 -/-mice significantly lost body weight and developed more severe 223 colitis compared to WT mice ( Fig. 2 ) (17). However, Hsp70
-/-/V-TG mice lost less body weight 224 and were less sensitive to DSS-induced damage compared to Hsp70 -/-mice ( Fig. 2 , A-C), 225
indicating that epithelial-specific expression of Hsp70 rescues Hsp70 -/-mice from DSS injury. It 226 is notable that the protection conferred by the epithelial-specific expression of Hsp70 was less 227 than observed in WT mice, i.e. Hsp70
-/-/V-TG mice still had significant tissue damage and 228 inflammation (Fig. 2 , A-C). Combined with finding of cytokine expression profile from TNBS 229 model, these data raise the possibility that Hsp70 has other mechanisms and targets of action in 230 maintaining host mucosal homeostasis besides just protecting the colonic epithelial cells. 231
232
Similar to what was done in TNBS-treated mice, cytokines levels were measured in colonic 233 tissues in the three groups of mice. Under basal level, no differences in cytokine expressions 234
were noted among the groups. However, after DSS treatment, significantly higher levels of the 235 pro-inflammatory cytokines TNF-α, IFN-γ and IL-6 were found in Hsp70
On the other hand, IL-10 levels were significantly 237 lower in both Hsp70
-/-and Hsp70 -/-/V-TG mice compared to that in WT mice ( Fig. 2G ). Only TNF-238 α was significantly lower in Hsp70
-/-/V-TG mice compared to that in Hsp70 -/-mice, whereas the 239 expression of the other three cytokines was not significantly different between Hsp70 -/-mice and 240
Hsp70
-/-/V-TG mice. These data support that Hsp70 has a role in modulating immune cell IL-10 241 production, and when inhibited by active inflammation, augments the immune dysfunction 242 associated with experimental colitis. 243
244
Immunofluorescence staining and immunoprecipitation 245
Part of the epithelial specific-protection provided by Hsp70 is through the maintenance of the 246 integrity of tight junctional complexes (28, 30). To examine whether this could be solely through 247 intestinal epithelial Hsp70, intestinal barrier function was assessed in DSS-treated Hsp70 -/-and 248
Hsp70
-/-/V-TG mice (Fig. 3) . Under basal condition, no differences in epithelial permeability could 249 be detected in the three mouse groups using the FITC-dextran absorption assay. After DSS 250 treatment, there was a significant increased uptake of FITC-dextran in Hsp70 -/-mice at day 4 251 (when no histologic tissue damage is observed) and day 10 (when both gross and microscopic 252 inflammation are observed) compared to that in both WT and Hsp70 -/-/V-TG mice. Differences in 253 uptake of FITC-dextran were only observed between WT and Hsp70 -/-/V-TG mice at day 10, but 254 not at day 4 (Fig. 3A) . Thus, the epithelial-specific expression of Hsp70 appears to play an 255 important role in maintaining the tight junction and colonic epithelial integrity. However, the 256 improvement in barrier function in the Hsp70 -/-/V-TG mice still did not approach that of WT mice. 257
The expression pattern of ZO-1 in the colonic epithelium was then examined by 258 immunofluorescence and found to be significantly disrupted and irregular in Hsp70 -/-mice 259 compared with WT mice (32). These changes were much less in the presence of intestinal 260 epithelial Hsp70 (Fig. 3D) . Although increased expression of pro-inflammatory cytokines TNF-α 261
and IFN-γ in Hsp70 -/-mice could partially contribute to the dysfunction of ZO-1, forced 262 expression of Hsp70 in the epithelium was able to ameliorate severe of colitis and also the 263 integrity of ZO-1. Using an immunoprecipitation (IP) approach, colonic Hsp70 appeared to 264 associate with the tight junction protein ZO-1 but not with other tight junction proteins such as 265 claudin-1 and occludin (Fig. 3B) . Co-localization of Hsp70 and ZO-1 was further confirmed by 266
Immunofluorescence staining (Fig. 3C) (Fig. 4 , A-C) that was associated with significantly elevated levels of the pro-inflammatory 282 cytokines IFN-γ, TNF-α, and IL-6 in the colon (Fig. 4D ) and decreased levels of IL-10 283 production in CD4 + T cells collected from mesenteric lymph node (Fig. 4E ). In contrast, mice 284 receiving WT CD45RB low cells did not develop disease or only showed mild inflammation along 285 with far less tissue damage. These results strongly suggest that Hsp70 in Treg cells is 286 immunomodulatory and essential for the production of IL-10. 287
288
Western blot of ERK-phosphorylation pathway 289
Previous reports have shown that extracellular Hsp70 can regulate disease-associated 290 inflammatory responses by affecting IL-10 production (6, 7, 39) . However, our data showed that 291 intracellular Hsp70 was essential to IL-10 biosynthesis. IL-10 levels were measured in both 292 innate and adaptive immune cells isolated from WT and Hsp70 -/-mice. Hsp70 expression could 293 be detected under basal conditions in all WT cells, with relatively higher levels in macrophage 294 and dendritic cell (DC), and less in CD4 + T and B cells (data not shown). These cells were then 295 subjected to in vitro stimulation with either mitogen or LPS. The induced expression of IL-10 by 296 these cells was then compared between the two groups. As shown in Fig. 5 , A-D, the induced 297 levels of IL-10 were significantly greater in all cell types examined from WT mice, but much 298 less in cells from Hsp70 -/-mice by ELISA analysis. These differences were associated with 299 significantly lower phosphorylation levels of ERK in Hsp70-deficient cells compared to WT 300 cells (Fig. 5, E-H) . In contrast, the P38 and JNK phosphorylation were not affected by gene-301 targeted deletion of Hsp70 deficiency (Fig. 6) . Moreover, these differences were also observed in 302 both TNBS and DSS models in which there was decreased phosphorylation of ERK in 303 mesenteric lymph nodes from both Hsp70 -/-and Hsp70 -/-/V-TG mice compared to that in WT mice 304 (Fig. 7) . In addition, we also examined NF-κB phosphorylation and inflammatory cytokine 305 expression in B and T cells. There was a significant increase of NF-κB phosphorylation in B and 306
T cells from Hsp70
-/-mice after stimulation, but not at baseline compared to that in cells from 307
WT. There was also a trend of elevated expression of TNF-α and IFN-γ in B and T cells 308 collected from Hsp70 -/-mice after stimulation, but the differences were not significant (Fig. 8) . 309
These data support the notion that intracellular Hsp70 is essential to the regulation of IL-10, 310 mostly likely through the interaction with ERK phosphorylation. 311
312
IL10/Hsp70 double knockout mouse model 313
The IL10 -/-mouse strain is a chronic, T-cell mediated, genetic model of experimental colitis that 314 has been used extensively by many investigators (10). In our facility, only about 20-30% of these 315 mice developed spontaneously colitis (Fig. 9A) (12) . To assess whether Hsp70 plays a role in the 316 development and/or progression of chronic colitis, Hsp70 -/-mice were bred with IL10 -/-mice to 317 obtain IL10/Hsp70 double knockout (IL10 -/-/Hsp70 -/-) mice. These mice were followed for up to 318 6 months of age and the penetrance of spontaneous of colitis measured by histology, disease 319 index, and colonic mucosal cytokine levels. IL10 -/-/Hsp70 -/-mice exhibited earlier onset of colitis 320 with a 100% penetrance (10/10) by 6 months of age (Fig. 9, A-C) . To determine the relative 321 importance of intestinal and non-intestinal epithelial Hsp70 in this model, the villin-promoter 322
Hsp70 transgene was also introduced into IL10 -/-/Hsp70 -/-mice. As shown in Fig. 8 colitis showed significantly elevated TNF-α, IFN-γ, IL-6 and IL-17 (Fig. 9, D-G) . More 326 importantly, the pattern of cytokine production in IL10 -/-/Hsp70 -/-mice with colitis was similar to 327 those in IL10
-/-and IL10
-/-/Hsp70 -/-/V-TG mice that also developed colitis (Fig. 9, D-G) . Thus, 328 these data suggest that an important role for intestinal epithelial Hsp70 in maintaining intestinal 329 homeostasis in the IL-10 -/-model. They further illustrate that Hsp70 plays an anti-inflammatory 330 role mediated through IL-10 production, as the inflammatory cytokines patterns between IL10 -/-
331
and IL10
-/-/Hsp70 -/-mice with colitis were very similar. 332
333
DISCUSSION 334
Inducible Hsp70, a highly conserved protein and molecular chaperone, is a multifunctional 335 protein that is expressed in many cell types (13, 20, 40) . Several studies have shown a link 336 between inflammatory bowel disease (IBD) and the down-regulation of colonic Hsp70 in human 337 IBD and experimental colitis (41, 42) . In the context of diseases like IBD, the relative roles of 338 Hsp70 in mediating epithelial cytoprotection and immune functions are poorly defined, in large 339 part due to the unavailability of suitable model systems that can discriminate between these 340
processes. 341 342
There is widely expressed Hsp70 in epithelium and lamina propria along the colon as Hsp70 is a 343 stress protein and can be induced by intestinal microbial signals (16, 23, 29, 37 (3, 11, 27) . In addition to its epithelial cytoprotection, Hsp70 has anti-359 inflammatory feature through maintaining IL10 production during colonic colitis (Fig. 10) . In the 360 previous reports, it was hypothesized that Hsp70 soluble form was able to bind to cell surface 361 receptor and signaling through TLR2 via ERK to induce IL-10 secretion (6). However, prior to 362 our work, little is known about the role of intracellular Hsp70 in immune regulation. Another 363 reason leads us to focus on the intracellular immunoregulation of Hsp70 is the availability of the 364
Hsp70
-/-mouse and the observation that Hsp70 -/-mice have decreased production of IL-10 during 365 colitis. Lack of sufficient induction of IL-10 during experimental colitis was observed in both 366
-/-and Hsp70 -/-/V-TG mice after DSS and TNBS treatment. Because DSS is directly toxic to 367 gut epithelial cells of mucosa and disrupts the integrity of the mucosal barrier (33), epithelial 368 specific expression of Hsp70 can ameliorate DSS-induced colitis phenotype of Hsp70 -/-mice. 369
However, it could not rescue TNBS induced colitis because TNBS colitis is mediated by Th1 370 response (21). Moreover, there are no differences of IFN-γ and IL-10 production during TNBS 371 colitis in both Hsp70
-/-and Hsp70 -/-/V-TG mice. These results suggest that susceptibility to colitis 372 in Hsp70 -/-mouse is due to impaired intracellular Hsp70-dependent IL-10 production and the 373 increased production of proinflammatory cytokines. 374
375
More importantly, results from rescue study using CD45RB high transfer model confirmed our 376 finding that intracellular Hsp70 regulates IL-10, as the ability of CD4 + regulatory T cells to 377
correct CD45RB high induced colitis is totally dependent upon IL-10 generation (5, 8). Another 378 implication of this model is to test whether the extracellular Hsp70 or intracellular Hsp70 is 379
dominant in driving IL-10 production in vivo. There is a widely Hsp70 production in Rag -/-mice, 380 which is expressed in colonic mucosa, macrophage and DCs. In theory, if extracellular Hsp70 is 381 the major driver of IL-10 production, CD4 + regulatory T cells from both WT and Hsp70 -/-mice 382 can be stimulated to make IL-10 after transfer and then in turn to lessen CD45RB high induced 383 colitis. In contrast, based on our data, CD4 + regulatory T cells from Hsp70 -/-mice cannot rescue 384
CD45RB
high induced colitis suggesting that intracellular Hsp70 is a primary driver of IL-10 385 production in immune cells. This is further supported by the ELISA data from both the DSS and 386 TNBS colitis models where we did not detect any significant differences in IL-10 in colonic 387 mucosa between Hsp70 -/-and Hsp70 -/-/V-TG mice. While these data are suggestive that 388 intracellular Hsp70 has a strong immunodulatory role, we cannot rule out a role for extracellular 389
Hsp70. Its effects can be diminished as a consequence of blockage of intracellular Hsp70-390 involved signal pathway of IL-10 production in active colitis. 391 392 IL-10 is the key cytokine with anti-inflammatory properties, has an essential role in IBD by 393 limiting the immune response and preventing damage to the gastrointestinal tract (19, 31, 36) . 394
Previous studies show the MAPK cascade especially ERK activation is associated with IL-10 395 expression regulation in all immune cells given IL-10 is down-regulated in the presence of 396 chemical inhibitors of ERK or in ERK deficient mice (2, 35, 43) . In addition, both ERK and p38 397 contribute IL-10 induction in macrophages and dendritic cells (25, 34) . We found that 398 immunocytes from Hsp70 deficient mice had significant less IL-10 expression compared to cells 399 from WT mice after either LPS or mitogen stimulation although both groups had escalated IL-10 400 expression compared to their basal level after stimulation. Furthermore, ERK phosphorylation, 401 but not p38 or JNK phosphorylation, was much diminished in cells with Hsp70 deficiency after 402 stimulation suggesting that Hsp70 regulates IL-10 production by specifically affecting ERK 403 phosphorylation pathway (Fig. 10) . However, it is still not clear how Hsp70 affects ERK 404 activation because we do not find any direct bindings between ERK and Hsp70 by co-405 immunoprecipitation (data not shown). As Hsp70, a molecular chaperone, interacts with key 406 regulators of many signal transduction pathways under stress (14), it is speculated that it may 407 interact with either upstream kinase such as Raf/MEK or MAPK phosphatases to activate 408 MAPK/ERK phosphorylation (22, 26) . Moreover, Hsp70 regulated IL-10 production is 409 immunocyte specific in this study because there are no differences of IL-10 production in colonic 410 tissue between Hsp70 -/-and Hsp70 -/-/V-TG mice. Bonferroni's multiple comparisons test. * P < 0.05, ** P < 0.01, *** P < 0.001, and n ≥ 6 in 492 each group. 
508
/Hsp70 -/-/V-TG mice. ZO-1 is stained in green and cell nucleus is in blue. Scale bars represent 50 509 um. Bars represent mean ± SD. Data were analyzed by one-way ANOVA with Bonferroni's 510 multiple comparisons test. ** P < 0.01, *** P < 0.001, **** P < 0.0001 and n ≥ 6 in each group. Mesenteric lymph nodes from mice with and without TNBS and DSS treatment were collected 593 respectively. ERK-phosphorylation status was compared among groups by western blot. No 594 difference of ERK-phosphorylation was detected in mice without colitis. But significantly lower 595 levels of ERK phosphorylation were detected in mesenteric lymph nodes from Hsp70 -/-and 596
Hsp70
-/-/V-TG mice compared to those from WT mice after TNBS (A and B) and DSS treatments 597 (C and D) respectively. Bars represent mean ± SD. Data were analyzed by one-way ANOVA 598 with Bonferroni's multiple comparisons test. * P < 0.05, n = 6 in each group and experiment was 599 performed by two times independently. 
